摘要:
A pharmaceutical composition for treating bronchitis and preparation method thereof. Said pharmaceutical composition consists of EPHEDRAE HERBA, GYPSUM FIBROSUM, FORSYTHIAE FRUCTUS, SCUTELLARIAE RADIX, MORI CORTEX, ARMENIACAE SEMEN AMARUM, PEUCEDANI RADIX, PINELLIAE RHIZOMA, etc. Said pharmaceutical composition is useful in relieving cough, eliminating phlegm, relieving asthma and resisting inflammation, so it has good curative effects on the acute tracheobronchitis.
摘要:
The present disclosure relates to a mulberry extract used in preparation of a drug for reducing animal weight. The mulberry extract comprises: 3% to 99% of an alkaloid, 0.2% to 70% of a polysaccharide, 0% to 50% of an amino acid, 0% to 10% of flavone, and 0% to 25% of other components. The mulberry extract of the present disclosure can be used for controlling weight gain, and has a good therapeutic effect on type 2 diabetes with obesity.
摘要:
The present invention belongs to the field of nutraceuticals or functional agents with immunostimulating capacity for triggering mechanisms of the innate immune response at a mucosal level. More specifically, it refers to the use of the compound D-fagomine as immunostimulating agent of the innate immune response in the mucosa and for the prevention or prophylaxis of inflammatory processes or diseases associated with an overactivation of the humoral immune response. The invention also relates to a composition comprising D-fagomine for the above referenced application.
摘要:
Compositions and preparation method thereof, said compositions comprise an extract from a mixture comprising Cyclocarya paliurus leaves and one or more herbs selected from the group consisting of Mori Cortex, Dendrobii Caulis and Citri Reticulatae Pericarpium, said compositions can treat diabetes, hyperglycemia, hypertension and/or hyperlipidemia.
摘要:
The present invention provides dietary compositions comprising mulberry extract, coffee extract, bean extract, optionally, dietary fibers, and a nutraceutically acceptable carrier. The present invention further provides methods for preventing the increase in postprandial hyperglycemia and hypoglycemia, hyperinsulinemia and diseases and disorders associated therewith, including, endothelial dysfunction, inflammatory conditions, oxidative stress, hyperlipidemia, and consecutive pathologies like insulin resistance, diabetes, visceral obesity, hypertension and cardiovascular diseases.